<DOC>
	<DOC>NCT00956215</DOC>
	<brief_summary>The study drug, Aprepitant, is currently used to control chemotherapy induced nausea and vomiting and is also approved for post-operative nausea and vomiting. The investigators' evaluation of it in morbidly obese patients will demonstrate its ability to control nausea and vomiting post-operatively in this subset of patients.</brief_summary>
	<brief_title>Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients</brief_title>
	<detailed_description>The purpose of this study is to evaluate the effectiveness of Aprepitant, also known as Emend, in reducing post-operative nausea and vomiting in morbidly obese patients. Post-operative nausea and vomiting that occurs in morbidly obese patients can greatly increase the chances of complications during the post-operative period. By treating morbidly obese patients with Aprepitant, the goal is to reduce the risk of such complications that may be induced by nausea and vomiting.</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea and Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Subjects included in this study must be: Female At least 18 years of age Nonsmoking At high risk for PONV Obese with a BMI of at least 45 kg/m2 Undergoing upper gastrointestinal surgery requiring postoperative opioid analgesia Subjects will be excluded if: They have a known allergy to Aprepitant or Ondansetron They are currently taking Orap (pimozide), Seldane (terfenadine), Hismanal (astemizole), or Propulsid (cisapride) They are pregnant They are breastfeeding They plan on getting pregnant in the 2 months following surgery They are not able to receive patient controlled analgesia (PCA) following surgery They have a known drug or alcohol abuse problem They have chronic nausea and vomiting</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>post operative</keyword>
	<keyword>obese</keyword>
</DOC>